Arbutus Biopharma

$3.18
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.46 (-12.71%) As of 7:41 PM UTC today

Why Robinhood?

You can buy or sell ABUS and other stocks, options, and ETFs commission-free!

About ABUS

Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA. The listed name for ABUS is Arbutus Biopharma Corporation Common Stock.

CEO
William H. Collier
Employees
80
Headquarters
Warminster, Pennsylvania
Founded
2005
Market Cap
258.97M
Price-Earnings Ratio
Dividend Yield
Average Volume
2.72M
High Today
$3.60
Low Today
$3.01
Open Price
$3.60
Volume
3.83M
52 Week High
$9.02
52 Week Low
$0.88

ABUS News

Benzinga7h

Recap: Arbutus Biopharma Q4 Earnings

Shares of Arbutus Biopharma (NASDAQ:ABUS) fell 6.0% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 50.
BenzingaMar 3

Earnings Preview: Arbutus Biopharma

On Thursday, March 04, Arbutus Biopharma (NASDAQ:ABUS) will release its latest earnings report. Check out Benzinga's preview to understand the implications. Ne

ABUS Earnings

-$0.73
-$0.49
-$0.24
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.22 per share
Actual
-$0.23 per share
Replay Earnings Call

You May Also Like

MACQU
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure